48 results
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc
2 May 24
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
6:03am
the holistic approach the Company takes to address environmental, social and governance priorities, including energy and emissions, addressing
8-K
EX-10.1
AUPH
Aurinia Pharmaceuticals Inc
21 Sep 23
Aurinia Board of Directors Appoints Dr. Robert T. Foster as New Board Director
4:06pm
voting policy, share ownership guidelines, fraud policy, and other governance guidelines and policies of the Company that are applicable (collectively … or governance structure, (D) any waiver, amendment or modification to the Company’s Articles of Amalgamation or Company’s By-law No. 2 (the “Bylaws”), (E
8-K
EX-99.1
jzqe577tfodd3u6
21 Sep 23
Aurinia Board of Directors Appoints Dr. Robert T. Foster as New Board Director
4:06pm
8-K
EX-99.1
3dvtnhjq08p8gas60ate
21 Aug 23
Dr. Daniel G. Billen appointed Chair of the Board of Directors
4:11pm
8-K
EX-99.1
4cteyrdtmhg1n1ukt
4 May 23
Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results
6:06am
PX14A6G
y4g05qye
26 Apr 23
Letter to shareholders
10:20am
DEFA14A
l2jgv8a
18 Apr 22
Additional proxy soliciting materials
7:36am
DEF 14A
d68t7poo5p
10 May 21
Definitive proxy
4:06pm
PRE 14A
kady u9zmyuju9kb9ef
27 Apr 21
Preliminary proxy
4:32pm
10-K
6hfsu7
24 Feb 21
Annual report
4:09pm
6-K
EX-99.2
faz1t2tyvvai
30 Dec 20
Material Change Report
5:30pm
SUPPL
pnj5pu1te i08x
23 Jul 20
Supplemental materials (foreign)
4:06pm
SUPPL
hnexrarjxh49mzb
26 Jun 20
Supplemental materials (foreign)
4:08pm